Patents
Patents for C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
03/2013
03/20/2013CN102985413A Tricarbonyl technetium-99m or rhenium-188 label ring RGD derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseas
03/13/2013CN102964566A Method for preparing polyisocyanate containing formimidoyl oxadiazine diketone
03/06/2013CN101142175B Peptidic compounds
03/05/2013US8389505 Adamantane derivatives of AZA-crown ethers and their use in treatment of tumor
02/2013
02/28/2013US20130053530 Method for preparing a poly(ether sulfonimide or -amide) copolymer using cyclic oligomers
02/13/2013CN102933565A Cyclic carbodiimide compound
02/12/2013CA2539842C Amidines and derivatives thereof and pharmaceutical compositions containing them
02/07/2013WO2012142457A3 Macrolactam compounds and methods for the treatment of malaria
02/05/2013CA2591033C Heterocyclic aspartyl protease inhibitors
01/2013
01/15/2013CA2430133C Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
01/01/2013US8343913 Hsp90, buffering and drug resistance
12/2012
12/27/2012WO2012142457A8 Macrolactam compounds and methods for the treatment of malaria
12/27/2012WO2012122383A3 Pi3 kinase inhibitors and uses thereof
12/11/2012US8329904 Azacyclic derivatives
12/11/2012CA2563975C Compounds and compositions as cathepsin s inhibitors
11/2012
11/28/2012EP2527400A1 Polylactic acid composition
11/28/2012CN102344394B Preparation method of nitroguanidine and its derivatives N-methylnitroguanidine and oxadiazine
11/27/2012US8318502 Long wavelength fluorogenic intracellular ion indicators that are well retained in the cytosol
11/13/2012US8309540 HCV NS3 protease inhibitors
10/2012
10/31/2012EP2516532A2 Polyoxaziridines and use thereof as a cross-linking agent, especially in coating materials and adhesives
10/26/2012WO2012096934A3 Inhibitors of retroviral replication
10/25/2012US20120270881 Conformationally constrained, fully synthetic macrocyclic compounds
10/18/2012WO2012142457A2 Macrolactam compounds and methods for the treatment of malaria
10/17/2012EP2509967A1 Novel 24-membered cyclooctadepsipeptides from fungal strains and their use as anthelmintics or endoparasiticides
10/11/2012US20120258993 Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents
10/10/2012EP2507219A2 Synthesis of syrbactin proteasome inhibitors
10/10/2012CN101007763B Intermediates used in the preparation of arthropodicidal oxadiazines
10/03/2012CN102712802A Polylactic acid composition
09/2012
09/20/2012US20120238747 Transfection reagents
09/18/2012US8268996 Compounds and compositions as cathepsin S inhibitors
09/13/2012US20120231376 Fluorourethane as an additive in a photopolymer formulation
09/13/2012US20120227545 Aqueous leaching process for recovery of precious metals with addition of di-thiooxamide ligand
09/13/2012CA2829558A1 Pi3 kinase inhibitors and uses thereof
09/11/2012US8263596 Kinase inhibitors and method of treating cancer
09/11/2012CA2445159C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
09/04/2012US8258345 Hydroxylation of β-dicarbonyls with zirconium catalysts
08/2012
08/28/2012US8252814 Agents and crystals for improving excretory potency of urinary bladder
08/21/2012US8246854 Organic catalyst with enhanced solubility
08/15/2012EP2044004B1 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity
08/14/2012US8242112 Heterocyclic aspartyl protease inhibitors
08/01/2012EP1888543B1 Apoptosis promoters
07/2012
07/18/2012CN102584739A Carboxyl benzyl replaced nitrogen dioxide crown ether derivative and synthesizing method thereof
07/18/2012CN101072781B Macrocyclic quinazoline derivatives and their use as mtki
07/10/2012US8217063 Lactam-substituted dicarboxylic acids and use thereof
07/10/2012CA2537440C Malonamide derivatives blocking the activity of gama-secretase
07/04/2012CN101759691B Crown ether substitutional amino acid schiff base and transition metal complex and preparation method thereof
06/2012
06/26/2012CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor
06/19/2012CA2504448C Transcription factor modulating compounds and methods of use thereof
06/14/2012US20120149895 Process for dimethylation of active methylene groups
06/12/2012US8198101 Bifunctional polyazamacrocyclic chelating agents
06/06/2012CN101391953B Preparation of arthropodicidal oxadiazines
05/2012
05/31/2012WO2012069859A1 Fluorescent dyes sensitive to sodium ions and optionally to potassium ions, process for their preparation and their use
05/31/2012WO2011085793A3 Polyoxaziridines and use thereof as a cross-linking agent, especially in coating materials and adhesives
05/30/2012CN102482238A 新颖的缀合物、其制备方法及其治疗用途 Novel conjugates, their preparation and their therapeutic use
05/23/2012EP1660884B1 Crown ether derivatives
05/16/2012EP2268625B1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
05/16/2012CN1854128B Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/09/2012EP2448929A1 Novel conjugates, preparation thereof, and therapeutic use thereof
05/09/2012CN102442959A Process for preparation of polyisocyanates and use thereof
05/03/2012US20120108808 Method for preparing (s)-5-chloro-n-((3-(4-(5,6-dihydro-4h-1,2,4-oxadiazin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide derivatives
05/03/2012US20120108499 Peptoid compounds
04/2012
04/25/2012CN102428074A α-(N-苯磺酰氨基)环烷基衍生物 α- (N- phenyl-sulfonyl-amino) cycloalkyl derivatives
04/17/2012US8158827 Transfection reagents
04/11/2012CN101723913B O-substituted dioxazine compound with bactericidal activity, preparation method thereof and application thereof
03/2012
03/28/2012CN102391261A N-substituted dioxazine compound as well as preparation method and application thereof
03/22/2012WO2011149250A3 Tricarbonyl technetium-99m or rhenium-188 label ring rgd derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseases
03/08/2012US20120058891 Oxadizine-Substituted Arylamides
02/2012
02/22/2012EP2420493A1 Haloalkylsulfonanilide derivative
02/21/2012US8119566 use as pesticides and/or herbicides and/or microbicides; for the selective control of weeds; synergistic; low application rates and concentrations; in particular in cereals (especially wheat)
02/08/2012CN102344394A Preparation method of nitroguanidine and its derivatives N-methylnitroguanidine and oxadiazine
02/08/2012CN101287731B 二噁嗪取代的芳基酰胺和噁二嗪取代的芳基酰胺 Dioxazine-substituted aryl amide and oxadiazine substituted aryl amide
02/02/2012US20120029187 Haloalkylsulfonanilide derivative
02/02/2012US20120028971 Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof
01/2012
01/26/2012US20120022053 Oxadiazine Derivatives
01/25/2012EP2408756A1 Alpha-(n-benzenesulfonamido)cycloalkyl derivatives
01/24/2012CA2494340C Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections
01/18/2012EP2406215A1 Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof
01/18/2012CN102320977A Cyclic carbodiimide compounds
12/2011
12/15/2011WO2011155624A1 Cyclic carbodiimide compound
12/06/2011USRE43003 Epothilone derivatives
12/01/2011WO2011149250A2 Tricarbonyl technetium-99m or rhenium-188 label ring rgd derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseases
12/01/2011CA2800958A1 Macrocyclic compounds useful as inhibitors of histone deacetylases
11/2011
11/23/2011CN101239955B Method for producing fungicide composition
11/22/2011US8062995 Dioxazine-substituted arylamides
11/16/2011CN102245703A Resin composition containing cyclic carbodimide
11/16/2011CN102245679A Method for using cyclic carbodimide
11/16/2011CN102245585A Cyclic carbodiimide compounds
11/16/2011CN102241643A 1-heterocycle-5-substituted phenyl-1-pentanone compound and preparation method and application thereof
11/10/2011US20110275802 Method for modifying diisocyanates
10/2011
10/27/2011WO2011069045A3 Synthesis of syrbactin proteasome inhibitors
10/27/2011US20110263598 Kinase inhibitors and method of treating cancer
10/26/2011EP2380883A1 Cyclic carbodiimide compounds
10/26/2011CN102225917A Preparation method of organic/layered double hydroxide (LDH) complex
10/20/2011WO2011129501A1 Method for preparing a poly(ether sulfonimide or -amide)copolymer using cyclic oligomers
10/20/2011US20110257254 Adamantane Derivatives Of Aza-Crown Ethers And Their Use In Treatment Of Tumor
10/20/2011US20110253931 Organic catalyst with enhanced solubility
10/13/2011US20110251384 Cyclic carbodiimide compounds
10/12/2011EP2374833A1 Method for using cyclic carbodimide
10/12/2011CN102212042A Synthetic method of tetra-azacrown ether
1 2 3 4 5 6 7 8 9 10 11 12 ... 24